13
(1H, m, H-8), 3.27 (3H, s, OCH ). C NMR (100 MHz, CDCl , δ, ppm): 37.21 (C-1), 19.65 (C-2), 40.52 (C-3), 149.24 (C-4),
3
3
47.45 (C-5), 23.62 (C-6), 40.25 (C-7), 76.25 (C-8), 41.26 (C-9), 33.75 (C-10), 44.78 (C-11), 170.59 (C-12), 75.30 (C-13),
106.41 (C-14), 27.48 (C-15), 59.30 (C-16).
General Procedure for Reaction of Alantolactone or Isoalantolactone with Diazomethane, Diazoethane, or
Diazopropane. To a solution of lactone (1 or 2, 2.0 g each) in ether containing 2–3 drops of triethylamine was added an excess
ethereal solution of diazomethane, diazoethane, or diazopropane separately. It was kept overnight.After completion of reaction,
the solvent was evaporated to afford crystalline compounds in each case, which were identified as pyrazoline 1d (yield 1.81 g,
mp 98°C), 1e (yield 1.82 g, mp 70°C), or 1f (yield 1.88 g, mp 55°C), or 2d (yield 1.65 g, mp 118°C), 2e (yield 1.72 g,
mp 104°C), or 2f (yield 1.80 g, mp 73°C), respectively, for each reaction.
–1
1
Compound 1d. IR (KBr, ν, cm ): 2924, 1767, 1646, 1554. H NMR (400 MHz, CDCl , δ, ppm, J/Hz): 1.13 (3H, d,
3
13
J = 7.6, H-14), 1.28 (3H, s, H-15), 1.54–1.65 (4H, m, H-13, 16), 4.78–4.86 (1H, m, H-8), 5.04 (1H, d, J = 3.4, H-6). C NMR
(100 MHz, CDCl , δ, ppm): 42.19 (C-1), 21.28 (C-2), 38.58 (C-3), 33.01 (C-4), 152.81 (C-5), 113.39 (C-6), 42.07 (C-7),
3
101.55 (C-8), 42.66 (C-9), 28.56 (C-10), 78.38 (C-11), 172.94 (C-12), 32.80 (C-13), 16.80 (C-14), 22.82 (C-15), 78.12 (C-16).
–1
1
Compound 1e. IR (KBr, ν, cm ): 2929, 1763, 1670, 1554, 1170, 888. H NMR (400 MHz, CDCl , δ, ppm, J/Hz):
3
13
1.23 (3H, d, J = 7.8, H-14), 1.26 (3H, s, H-15), 1.57 (3H, d, J = 7.3, H-17), 4.73–4.76 (1H, m, H-8). C NMR (100 MHz,
CDCl , δ, ppm): 38.53 (C-1), 22.74 (C-2), 37.55 (C-3), 33.04 (C-4), 145.48 (C-5), 118.81 (C-6), 37.87 (C-7), 86.59 (C-8),
3
40.79 (C-9), 32.76 (C-10), 76.46 (C-11), 172.75 (C-12), 42.02 (C-13), 18.74 (C-14), 24.68 (C-15), 43.12 (C-16), 16.83 (C-17).
–1
1
Compound 1f. IR (KBr, ν, cm ): 2965, 1745, 1656, 1555, 1169, 870. H NMR (400 MHz, CDCl , δ, ppm, J/Hz):
3
0.96 (3H, t, J = 7.2, H-18), 1.22 (3H, d, J = 7.7, H-14), 1.27 (3H, s, H-15), 1.33–1.37 (2H, m, H-17), 1.52–1.84 (2H, m, H-13),
13
4.74–4.76 (1H, m, H-8), 5.37 (1H, d, J = 3.7, H-6). C NMR (100 MHz, CDCl , δ, ppm): 38.5 (C-1), 20.10 (C-2), 36.42 (C-3),
3
35.70 (C-4), 144.20 (C-5), 122.80 (C-6), 36.97 (C-7), 81.60 (C-8), 41.21 (C-9), 30.6 (C-10), 76.90 (C-11), 172.33 (C-12),
46.00 (C-13), 19.92 (C-14), 25.4 (C-15), 59.77 (C-16) 28.13 (C-17), 9.00 (C-18).
–1
1
Compound 2d. IR (KBr, ν, cm ): 3084, 1761, 1643, 1549, 1212, 891. H NMR (400 MHz, CDCl , δ, ppm, J/Hz):
3
0.86 (3H, s, H-15), 1.23–1.33 (2H, m, H-16), 2.31–2.37 (2H, m, H-13), 4.45 (1H, d, J = 1.20, H-14), 4.79 (1H, d, J = 1.35,
13
H-14), 5.52–5.54 (1H, m, H-8). C NMR (100 MHz, CDCl , δ, ppm): 42.02 (C-1), 20.42 (C-2), 41.30 (C-3), 149.02 (C-4),
3
46.29 (C-5), 21.86 (C-6), 34.58 (C-7), 78.03 (C-8), 43.33 (C-9), 22.64 (C-10), 106.55 (C-11), 173.11 (C-12), 36.72 (C-13),
17.80 (C-14), 103.15 (C-15), 78.75 (C-16).
–1
1
Compound 2e. IR (KBr, ν, cm ): 3078, 1763, 1676, 1549, 1216, 891. H NMR (400 MHz, CDCl , δ, ppm, J/Hz):
3
13
1.10 (3H, s, H-15), 1.50 (3H, d, J = 7.2, H-17), 3.94–3.96 (1H, m, H-16), 4.50–4.52 (1H, m, H-8), 4.75 (2H, br.s, H-14). C NMR
(100 MHz, CDCl , δ, ppm): 41.54 (C-1), 24.83 (C-2), 40.51 (C-3), 149.40 (C-4), 46.40 (C-5), 26.22 (C-6), 36.83 (C-7), 76.64
3
(C-8), 42.01 (C-9), 34.34 (C-10), 106.62 (C-11), 173.46 (C-12), 43.57 (C-13), 120.11 (C-14), 22.69 (C-15), 46.24 (C-16),
19.03 (C-17).
–1
1
Compound 2f. IR (KBr, ν, cm ): 3082, 2964, 1769, 1707, 1527, 1216, 893. H NMR (400 MHz, CDCl , δ, ppm,
3
J/Hz): 1.65–1.89 (3H, m, H-13, 16), 1.10 (3H, t, J = 5.6, H-18), 1.24 (3H, s, H-15), 4.47, 4.79 (each 1H, br.s, H-14), 4.84–4.88
13
(1H, m, H-8), 5.16 (2H, d, J = 3.8, H-6), 6.66 (dq, J = 1.96, 7.7, H-17). C NMR (100 MHz, CDCl , δ, ppm): 38.58 (C-1),
3
22.69 (C-2), 37.79 (C-3), 149.07 (C-4), 56.4 (C-5), 24.16 (C-6), 33.76 (C-7), 77.37 (C-8), 42.73 (C-9), 29.69 (C-10), 106.58
(C-11), 171.21 (C-12), 45.69 (C-13), 109.43 (C-14), 21.65 (C-15), 58.95 (C-16), 23.10 (C-17), 10.39 (C-18).
General Procedure for Allylic Oxidation of Isoalantolactone Using SeO /TBHP. Selenium dioxide (10.0 mg) was
2
added to tert-butyl hydroperoxide (3.0 mL, 70%), and the mixture was stirred for 30 min to which a solution of isoalantolactone
(2, 2.0 g) in dichloromethane (25.0 mL) was added. The reaction mixture was stirred for 4 h followed by dilution with cold
water and extraction with dichloromethane (2 × 25 mL). The combined organic extracts were washed with water and dried
(Na SO ). Evaporation of the solvent afforded a mixture (1.9 g) of two compounds, which were chromatographed over silica
2
4
gel to give pure compounds 2g (yield 0.6 g, mp 144°C) and 2h (yield 0.2 g, mp 161°C).
–1
1
Compound 2g. IR (KBr, ν, cm ): 3454, 2935, 1747, 1662, 1263, 1162, 1084, 952, 906, 820. H NMR (400 MHz,
CDCl , δ, ppm, J/Hz): 0.82 (3H, s, H-15), 2.98–3.04 (1H, m, H-7), 4.58 (1H, t, J = 7.52, H-3), 4.50–4.53 (1H, m, H-8), 5.61
3
13
and 6.13 (each 1H, br.s, H-14), 4.33 and 4.99 (each 1H, br.s, H-13). C NMR (100 MHz, CDCl , δ, ppm): 37.00 (C-1), 35.68
3
(C-2), 73.26 (C-3), 150.13 (C-4), 40.98 (C-5), 29.04 (C-6), 40.21 (C-7), 76.91 (C-8), 40.43 (C-9), 27.05 (C-10), 142.09 (C-11),
170.74 (C-12), 120.31 (C-13), 109.83 (C-14), 16.94 (C-15).
–1
1
Compound 2h. IR (KBr, ν, cm ): 3436, 2930, 1729, 1659, 1420, 1264, 1162, 822. H NMR (400 MHz, CDCl , δ,
3
ppm, J/Hz): 0.94 (3H, s, H-15), 3.32–3.38 (1H, m, H-7), 4.53–4.58 (1H, m, H-8), 4.43 (1H, br.s, H-3), 4.89 and 5.10 (each 1H,
13
br.s, H-14), 5.65 (1H, d, J = 2.28, H-13), 6.13 (1H, d, J = 2.76, H-13). C NMR (100 MHz, CDCl , δ, ppm): 29.06 (C-1),
3
211